Dr. Boughey on Surgical Management of Patients With Node-Positive Breast Cancer

Video

In Partnership With:

Judy C. Boughey, MD, chair, Division of Surgery Research, Mayo Clinic, discusses the surgical management of patients with node-positive breast cancer.

Judy C. Boughey, MD, chair, Division of Surgery Research, Mayo Clinic, discusses the surgical management of patients with node-positive breast cancer.

Traditionally, patients with node-positive breast cancer received a full axillary dissection. However, work is investigating whether patients who receive neoadjuvant chemotherapy can avoid the morbidity of the procedure and receive a sentinel lymph node surgery instead. Trials to date have shown false negative rates with the procedure, but there have been several advances in approaches that are driving down the false negative rate and improving the safety of the procedure, Boughey explains.

Examples of these approaches include ensuring that the surgeon uses a dual tracer to increase the identification rate of the sentinel node and decrease the false negative rate associated with sentinel lymph node surgery. Another technique is using a clip to identify the lymph node during surgery. A third technique that is widely adopted is the use of immunohistochemistry to better select patients who stand to benefit from an axillary lymph node dissection.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD